VAZULI 20 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 60
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1256803630151 -
GGREM
528525090242103 -
Código de barras
7899547555592
O que a fonte publica
- Detentor do registro
- PRATI DONADUZZI & CIA LTDA
- Princípios ativos
- RIVAROXABANA
- Embalagem
- 20 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 60
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Similar
- Classe terapêutica
- B1F - INIBIDORES DIRETOS DO FATOR XA
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "VAZULI 20 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 60",
"holder": "PRATI DONADUZZI & CIA LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7899547555592"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "528525090242103",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "73.856.593/0001-66",
"priceRegime": "Regulado",
"productName": "VAZULI",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "20 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 60",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "338.75",
"icms-12": "384.94",
"icms-17": "408.13",
"icms-18": "413.11",
"icms-19": "418.21",
"icms-20": "423.44",
"icms-21": "428.80",
"icms-22": "434.29",
"icms-23": "439.93",
"icms-17.5": "410.61",
"icms-19.5": "420.81",
"icms-20.5": "426.10",
"icms-22.5": "437.10",
"icms-12-alc": "380.32",
"icms-17-alc": "403.23",
"icms-18-alc": "408.15",
"icms-19-alc": "413.19",
"icms-20-alc": "418.36",
"icms-21-alc": "423.65",
"icms-22-alc": "429.08",
"icms-23-alc": "434.66",
"withoutTaxes": "334.68",
"icms-17.5-alc": "405.68",
"icms-19.5-alc": "415.76",
"icms-20.5-alc": "420.99",
"icms-22.5-alc": "431.85"
},
"pisCofinsList": "Positiva",
"substanceText": "RIVAROXABANA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "466.93",
"icms-12": "530.60",
"icms-17": "562.56",
"icms-18": "569.43",
"icms-19": "576.46",
"icms-20": "583.67",
"icms-21": "591.06",
"icms-22": "598.62",
"icms-23": "606.40",
"icms-17.5": "565.98",
"icms-19.5": "580.04",
"icms-20.5": "587.33",
"icms-22.5": "602.50",
"icms-12-alc": "525.77",
"icms-17-alc": "557.44",
"icms-18-alc": "564.24",
"icms-19-alc": "571.21",
"icms-20-alc": "578.36",
"icms-21-alc": "585.67",
"icms-22-alc": "593.18",
"icms-23-alc": "600.89",
"withoutTaxes": "462.68",
"icms-17.5-alc": "560.83",
"icms-19.5-alc": "574.76",
"icms-20.5-alc": "581.99",
"icms-22.5-alc": "597.01"
},
"invalidBarcodes": [],
"activeSubstances": [
"RIVAROXABANA"
],
"therapeuticClass": "B1F - INIBIDORES DIRETOS DO FATOR XA",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1256803630151",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "B1F",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:528525090242103"